Your browser doesn't support javascript.
loading
HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen.
Göthlin Eremo, Anna; Tina, Elisabet; Wegman, Pia; Stål, Olle; Fransén, Karin; Fornander, Tommy; Wingren, Sten.
Afiliação
  • Göthlin Eremo A; Faculty of Medicine and Health, School of Health and Medical Sciences, Örebro University, SE-701 82 Örebro, Sweden.
  • Tina E; Clinical Research Centre, Örebro University Hospital, SE-701 85 Örebro, Sweden.
  • Wegman P; Department of Clinical Genetics, University Hospital, SE-581 85 Linköping, Sweden.
  • Stål O; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE-581 85 Linköping, Sweden.
  • Fransén K; Faculty of Medicine and Health, School of Health and Medical Sciences, Örebro University, SE-701 82 Örebro, Sweden.
  • Fornander T; Department of Oncology, Karolinska University Hospital, Karolinska Institute, SE-171 76 Stockholm, Sweden.
  • Wingren S; Faculty of Medicine and Health, School of Health and Medical Sciences, Örebro University, SE-701 82 Örebro, Sweden.
Int J Oncol ; 47(4): 1311-20, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26238412
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Moduladores Seletivos de Receptor Estrogênico / Receptor ErbB-4 Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Moduladores Seletivos de Receptor Estrogênico / Receptor ErbB-4 Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia